Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00625066 · ClinicalTrials.gov registry record
Biological, Genetic, and Lifestyle Risk Factors for Developing Colorectal Adenomas or Polyps in Participants Undergoing Colonoscopy
A clinical trial, sponsored by Vanderbilt University.
- Completed
- Registry status
- 8,108
- Enrollment target
NCT00625066: Completed study, sponsored by Vanderbilt University.
NCT00625066 is a clinical trial that has completed, run by Vanderbilt University. The registered enrollment target is 8,108 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00625066 has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- 8,108 participants
- Enrollment target
Study Summary
RATIONALE: Collecting and storing samples of tissue, blood, and other body fluids to test in the laboratory and gathering information about health and lifestyle from participants may help doctors learn more about cancer risk factors. PURPOSE: This clinical trial is looking at biological, genetic, and lifestyle risk factors for developing colorectal adenomas or polyps in participants undergoing colonoscopy.
Interventions
- OTHER biologic sample preservation procedure
- OTHER cytology specimen collection procedure
- OTHER medical chart review
- OTHER questionnaire administration
- OTHER survey administration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,108 participants |
| Start Date | 2003-01-01 |
| Est. Completion | 2025-11-30 |
What the finished NCT00625066 record still lists
NCT00625066 is an observational study that tracks outcomes without assigning an intervention. Its 8,108 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 5 interventions - of which biologic sample preservation procedure is the first listed.
NCT00625066 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00625066 about?
NCT00625066 is a clinical study titled "Biological, Genetic, and Lifestyle Risk Factors for Developing Colorectal Adenomas or Polyps in Participants Undergoing Colonoscopy". RATIONALE: Collecting and storing samples of tissue, blood, and other body fluids to test in the laboratory and gathering information about health and lifestyle from participants may help doctors learn more about cancer risk factors. PURPOSE: This clinical trial is looking at biological, genetic, a...
What is the current status of trial NCT00625066?
This trial is currently completed. The enrollment target is 8,108 participants. The study started on 2003-01-01. Estimated completion is 2025-11-30.
What interventions are being tested in trial NCT00625066?
The interventions under investigation include: biologic sample preservation procedure (OTHER), cytology specimen collection procedure (OTHER), medical chart review (OTHER), questionnaire administration (OTHER), survey administration (OTHER).
Who is sponsoring clinical trial NCT00625066?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06184945 · 8,100 participants · NA
Behavioral Economic & Staffing Strategies in the ICU
- NCT05593484 · 8,060 participants · NA
School Screening and Telemedicine Specialty Referral to Address Childhood Hearing Loss in Rural Alaska
- NCT06435806 · 8,200 participants · NA
Medical Illustration Design Characteristic Evaluation
- NCT00539162 · 8,000 participants · NA
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI